3-aminobenzamide has been researched along with clinprost in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, DI; Hwang, SJ; Kim, DW; Kim, J; Kim, JG; Kim, K; Kim, MH; Kim, SH; Koh, SH; Lee, SR; Park, Y; Song, CW; Yu, HJ | 1 |
1 other study(ies) available for 3-aminobenzamide and clinprost
| Article | Year |
|---|---|
The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals.
Topics: Animals; Benzamides; Blotting, Western; Brain; Brain Edema; Brain Infarction; Brain Ischemia; Caspase 3; Caspases; CD11b Antigen; Cell Count; Cell Death; Cyclooxygenase 2; Epoprostenol; Female; Functional Laterality; Glycogen Synthase Kinase 3; Immunohistochemistry; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Inflammation; Intercellular Adhesion Molecule-1; Isoenzymes; Magnetic Resonance Imaging; Male; Neuroprotective Agents; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Prostaglandin-Endoperoxide Synthases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Staining and Labeling; Time Factors | 2004 |